Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.

Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, Goff DC.

Am J Psychiatry. 2000 Jun;157(6):975-81.

PMID:
10831479
2.

Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.

Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC.

J Clin Psychiatry. 2005 Sep;66(9):1116-21.

PMID:
16187768
3.

Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.

Lamberti JS, Costea GO, Olson D, Crilly JF, Maharaj K, Tu X, Groman A, Dietz MB, Bushey MP, Olivares T, Wiener K.

J Clin Psychiatry. 2005 Jul;66(7):900-6.

PMID:
16013906
4.

Clozapine: diabetes mellitus, weight gain, and lipid abnormalities.

Henderson DC.

J Clin Psychiatry. 2001;62 Suppl 23:39-44. Review.

5.

Prevalence of obesity, lipid and glucose abnormalities in outpatients prescribed clozapine.

Leonard P, Halley A, Browne S.

Ir Med J. 2002 Apr;95(4):119-20.

PMID:
12090443
6.

Clozapine-associated elevation in serum triglycerides.

Gaulin BD, Markowitz JS, Caley CF, Nesbitt LA, Dufresne RL.

Am J Psychiatry. 1999 Aug;156(8):1270-2.

PMID:
10450273
7.

A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain.

Henderson DC, Fan X, Copeland PM, Borba CP, Daley TB, Nguyen DD, Zhang H, Hayden D, Freudenreich O, Cather C, Evins AE, Goff DC.

Acta Psychiatr Scand. 2007 Feb;115(2):101-5.

PMID:
17244173
8.

A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.

Kelly AC, Sheitman BB, Hamer RM, Rhyne DC, Reed RM, Graham KA, Rau SW, Gilmore JH, Perkins DO, Peebles SS, VanderZwaag CJ, Jarskog LF.

J Clin Psychopharmacol. 2014 Aug;34(4):441-5. doi: 10.1097/JCP.0000000000000159.

PMID:
24943389
9.

Clozapine and associated diabetes mellitus.

Popli AP, Konicki PE, Jurjus GJ, Fuller MA, Jaskiw GE.

J Clin Psychiatry. 1997 Mar;58(3):108-11.

PMID:
9108812
10.

The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.

Zhang R, Hao W, Pan M, Wang C, Zhang X, Chen DC, Xiu MH, Yang FD, Kosten TR, Zhang XY.

Hum Psychopharmacol. 2011 Aug;26(6):392-6. doi: 10.1002/hup.1220. Epub 2011 Aug 8.

PMID:
21826737
11.

Clozapine and hypertension: a chart review of 82 patients.

Henderson DC, Daley TB, Kunkel L, Rodrigues-Scott M, Koul P, Hayden D.

J Clin Psychiatry. 2004 May;65(5):686-9.

PMID:
15163256
13.

[Type 2 diabetes and dyslipidemia. Side effects of "Atypical" neuroleptics?].

Wetterling T.

Med Klin (Munich). 2003 Jul 15;98(7):364-7. Review. German.

PMID:
12937901
14.
15.

An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.

Henderson DC, Kunkel L, Nguyen DD, Borba CP, Daley TB, Louie PM, Freudenreich O, Cather C, Evins AE, Goff DC.

Acta Psychiatr Scand. 2006 Feb;113(2):142-7.

PMID:
16423166
16.

Association of initial antipsychotic response to clozapine and long-term weight gain.

Bai YM, Lin CC, Chen JY, Lin CY, Su TP, Chou P.

Am J Psychiatry. 2006 Jul;163(7):1276-9.

PMID:
16816235
17.

Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions.

Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA.

J Clin Psychopharmacol. 2008 Apr;28(2):132-7. doi: 10.1097/JCP.0b013e318166c4f7.

PMID:
18344722
18.
19.

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.

Lund BC, Perry PJ, Brooks JM, Arndt S.

Arch Gen Psychiatry. 2001 Dec;58(12):1172-6.

PMID:
11735847

Supplemental Content

Support Center